Shoulder Problem Pain: when insurers say no, reviewers often say yes
In 115 published external-review decisions involving shoulder problem pain, independent physician reviewers overturned the insurer’s denial 46.1% of the time.
Most-fought treatments for shoulder problem pain
| Category | Decisions | Overturned |
|---|---|---|
| MRI | 29 | 69% |
| Arthroscopy | 14 | 28.6% |
| Physical Therapy | 6 | 16.7% |
| Acupuncture | 6 | 66.7% |
| Pain Medication | 5 | 20% |
| Ligament Tendon Repair | 5 | 60% |
| Viscosupp Injection | 4 | 75% |
What the insurer actually argued
| Reason given | Decisions | Overturned |
|---|---|---|
Medical Necessity The plan said the care wasn’t medically necessary. The most common fight, and the most winnable. | 94 | 52.1% |
Experimental/Investigational The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument. | 18 | 16.7% |
Urgent Care Expedited reviews, decided in days rather than weeks. | 3 | 33.3% |
Where the denial was overturned
Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for shoulder surgery. According to one study, rotator cuff tear is the most common shoulder pathology. The authors noted that systematic rehabilitation is the mainstay treatment for partial thickness cuff tears and is also acceptable for the initial management of full thickness cuff tears. Rehabilitation in cuff tear consists of strengthening the core stabilizers along with the rotator cuff and deltoid muscles. The authors reported that indications for the repair of a full thickness cuff tear include failed rehabilitation for three months, acute traumatic tear, younger age, intractable pain, and good-quality muscle.
Findings: The physician reviewer found that the patient requested authorization and coverage for Oxycodone HCL 20mg tablets. The Centers for Disease Control and Prevention (CDC) guidelines for opioid therapy prescribing state that, “For patients already receiving opioid therapy, clinicians should carefully weigh benefits and risks and exercise care when changing opioid dosage. If benefits outweigh risks of continued opioid therapy, clinicians should work closely with patients to optimize nonopioid therapies while continuing opioid therapy”. Further, the CDC advised that clinicians should optimize other therapies and work closely with patients to gradually taper to lower dosages or, if warranted based on the individual circumstances of the patient, appropriately taper and discontinue opioids so long as the benefits do not outweigh the risks of continued opioid therapy.
Where the denial was upheld
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for a left shoulder surgery, matrix induced autologous chondrocyte implantation. Researchers explain, “Autologous chondrocyte implantation (ACI) and matrix-induced autologous chondrocyte implantation (MACI) are performed to treat focal chondral defects (FCDs); both are two-step procedures involving a biopsy, followed by transplantation.
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for surgical arthroscopy of the left shoulder with decompression and rotator cuff repair and coracoacromial ligament release for shoulder. Researchers explain, “Rotator cuff tear progression can be difficult to predict. Factors associated with tear enlargement include increasing symptoms, advanced age, involvement of two or more tendons, and rotator cable lesion. Nonsurgical treatment can be effective for patients with full-thickness tears.
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.
These outcomes come from California’s external review program — an independent physician panel whose decision binds the insurer. Every state has an equivalent, and internal appeals succeed even more often. If your care for shoulder problem pain was denied, the published record says the denial is worth fighting.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY